AGIC Capital To Acquire US Pharmaceutical Firm Ritedose For Asian Expansion

An investor consortium led by AGIC Capital, an Asia-Europe cross-border growth equity firm founded by former Deutsche Bank executive Henry Cai, has agreed to acquire U.S. pharmaceutical firm the Ritedose Corporation from private equity firm Olympus Partners.

No financial details were announced. AGIC did not disclose the identities of participating investors in an announcement.

"Our strategy is to select high value, innovative and well managed companies that have significant potential for growth but need the finance and expertise to do so, particularly in new markets such as Europe and Asia. Ritedose ticks all of those boxes," said Henry Cai, chairman of AGIC. "AGIC is fully committed to providing Ritedose with the resources and regional expertise to support the expansion of the customer base and identify business opportunities in China, and...

This news article comes via , who is the copyright owner of this information and news. has licensed the rights to this article and any republication or re-distribution in whole or in part of this content is strictly prohibited without the express consent of China Money Network

You May Also Like